Notice: ASA extends its thoughts and condolences to those affected by the disaster in Oklahoma. Donations to help aid this relief can be made through the American Red Cross website.

>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

Physician Fee Schedule Rule That Includes Chronic Pain Proposal Moves to the OMB Final review

Thursday, October 25, 2012

ASA has learned that the Centers for Medicare & Medicaid Services’ (CMS) Calendar Year (CY) 2013 Medicare Physician Fee Schedule proposed rule, which includes the controversial section regarding payment to nurse anesthetists for chronic pain services, has been sent to the Office of Management and Budget (OMB) for review.  The rule is scheduled to be issued as a final rule with comment period.  This means that, while most of the rule will be effectuated on a final basis (as of 1/1/13), certain provisions of the otherwise final regulation will be subject to further comment from the public, though it is unclear whether the chronic pain proposal will be one of those provisions subject to additional comment.

Following the OMB review, ASA expects the final rule with comment to be promulgated on or around November 1.  ASA will continue to closely monitor this situation and evaluate the need for additional action upon publication of the final rule. 

View the regulatory process.
Learn more about the Chronic Pain Proposal.

« Back to Washington Alerts